Anzeige
Mehr »
Login
Montag, 19.04.2021 Börsentäglich über 12.000 News von 660 internationalen Medien
InnoCan Pharma: CEO leakt Ergebnisse auf Twitter!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 853681 ISIN: JP3119600009 Ticker-Symbol: AJI 
Frankfurt
19.04.21
15:31 Uhr
16,500 Euro
-0,300
-1,79 %
1-Jahres-Chart
AJINOMOTO CO INC Chart 1 Jahr
5-Tage-Chart
AJINOMOTO CO INC 5-Tage-Chart
RealtimeGeldBriefZeit
16,40017,40022:31

Aktuelle News zur AJINOMOTO Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoMETABOLIC EXPLORER: METEX: Signature of the Share Purchase Agreement (SPA) for the transfer of 100% of the capital of Ajinomoto Animal Nutrition Europe (AANE).198Signature of the Share Purchase Agreement (SPA) for the transfer of 100% of the capital of Ajinomoto Animal Nutrition Europe (AANE) Favourable opinion from the employee representative bodies No...
► Artikel lesen
05.04.CDMO Ajinomoto to bring AstraZeneca fill-finish work to San Diego plant6
01.04.Ajinomoto and Bright Peak partner to develop immunocytokines2
AJINOMOTO Aktie jetzt für 0€ handeln
31.03.Ajinomoto Bio-Pharma Services erweitert Fertigungsvereinbarung mit AstraZeneca um die Herstellung von Arzneimitteln289Wetteren, Belgien (ots/PRNewswire) - Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), ein führender Anbieter von biopharmazeutischen Auftragsentwicklungs- und Produktionsdienstleistungen, freut sich...
► Artikel lesen
30.03.Ajinomoto Bio-Pharma Services Expands Manufacturing Agreement with AstraZeneca to Include Drug Product Manufacturing301WETTEREN, Belgium, March 30, 2021 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services...
► Artikel lesen
30.03.Ajinomoto, Bright Peak Enter Immunocytokines Research Pact2
26.03.Bright Peak Therapeutics, Inc.: Bright Peak Therapeutics Inc. and Ajinomoto Co., Inc. Enter into a Research Collaboration and License Agreement to Create Novel Immunocytokines485SAN DIEGO and TOKYO, March 25, 2021 (GLOBE NEWSWIRE) -- Bright Peak Therapeutics Inc., a biotechnology company developing next generation immunotherapies for cancer and autoimmune disease, and Ajinomoto...
► Artikel lesen
27.01.Humanigen and Ajinomoto expand manufacturing agreement for lenzilumab development7
27.01.Ajinomoto Bio-Pharma, Humanigen Expand Manufacturing Agreement4
27.01.Ajinomoto Bio-Pharma Services und Humanigen erweitern Vereinbarung zum "Fill and Finish" des COVID-19-Therapeutikums Lenzilumab, das kurz vor dem Abschluss der Phase-3-Studie steht340San Diego und Burlingame, Kalifornien (ots/PRNewswire) - Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), ein führender Anbieter im Bereich der biopharmazeutischen Auftragsentwicklung und Fertigung...
► Artikel lesen
27.01.Ajinomoto Bio-Pharma Services and Humanigen Expand Manufacturing Agreement to Support Fill Finish for Investigational COVID-19 Therapeutic, Lenzilumab, Nearing Completion of Phase 3 Study324SAN DIEGO and BURLINGAME, California, Jan. 27, 2021 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing...
► Artikel lesen
22.12.20Ajinomoto Bio-Pharma and Revance Therapeutics Partner4
22.12.20Ajinomoto Cambrooke, Inc. Continues to Expand Worldwide with the Acquisition of Nualtra Ltd.5
21.12.20Ajinomoto Cambrooke acquires Nualtra Limited2
21.12.20Ajinomoto Cambrooke, Inc. Continues to Expand Worldwide with the Acquisition of Nualtra Ltd.288Ajinomoto Cambrooke, Inc. has acquired Nualtra Limited, a medical nutrition company offering life-enhancing oral nutritional supplements in the UK and Ireland. Cambrooke, a global leader and innovator...
► Artikel lesen
21.12.20Technavio Research: Sports Nutrition Market Research In Europe 2020-2024- Featuring Abbott Laboratories, Ajinomoto Co. Inc., Glanbia Plc, Among Others to Contribute to the Market Growth | Technavio357The sports nutrition market in europe is poised to grow by USD 1.41 bn during 2020-2024, progressing at a CAGR of almost 8% during the forecast period. This press release features multimedia. View...
► Artikel lesen
30.11.20Technavio Research: Frozen Snack Food Market 2020-2024- Featuring Ajinomoto Co. Inc., Conagra Brands Inc. Among Others to Contribute to the Market Growth | Industry Analysis, Market Trends, Opportunities, and Forecast 2024300The frozen snack food market is poised to grow by USD 11.30 bn during 2020-2024, progressing at a CAGR of over 6% during the forecast period. This press release features multimedia. View the full...
► Artikel lesen
30.10.20Technavio Research: Global Frozen Food Market- Featuring Ajinomoto Co. Inc., Bonduelle SCA, Conagra Brands Inc., among others472The global frozen food market size is poised to grow by USD 64.69 billion during 2020-2024 progressing at a CAGR of about11% during the forecast period. Technavio suggests three forecast scenarios...
► Artikel lesen
22.10.20Technavio Research: The Spices and Seasonings Market 2020-2024- Featuring Ajinomoto Co. Inc., Associated British Foods Plc, Dohler GmbH, DS Group, Among Others337The spices and seasonings market is poised to grow by USD 3.66 billion during 2020-2024 progressing at a CAGR of about 4% during the forecast period. This press release features multimedia. View...
► Artikel lesen
16.10.20Ajinomoto-Aktie mit leichten Kursgewinnen373Die Aktie von Ajinomoto notiert am Freitag ein wenig fester. Zuletzt zahlten Investoren für das Wertpapier 17,25 Euro. Heute hat sich am Aktienmarkt die Aktie von Ajinomoto zwischenzeitlich um 0,88...
► Artikel lesen
Seite:  Weiter >>
37 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1